Exploring Advancements in the Treatment Landscape for Patients with Parkinson’s Disease

Dr. Robert Hauser, from the University of South Florida, provides an overview of Vyalev (foscarbidopa/foslevodopa), highlighting medication administration and mechanism of action, as well as phase 3 trial findings.